Virtue Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q4 | – | Sell |
-9,962
| Closed | -$2.71M | – | 273 |
|
2020
Q3 | $2.71M | Sell |
9,962
-3,695
| -27% | -$1.01M | 0.67% | 32 |
|
2020
Q2 | $3.97M | Buy |
+13,657
| New | +$3.97M | 0.91% | 19 |
|
2020
Q1 | – | Sell |
-2,079
| Closed | -$455K | – | 208 |
|
2019
Q4 | $455K | Sell |
2,079
-13,241
| -86% | -$2.9M | 0.13% | 156 |
|
2019
Q3 | $2.6M | Sell |
15,320
-2,168
| -12% | -$367K | 0.86% | 38 |
|
2019
Q2 | $3.21M | Buy |
+17,488
| New | +$3.21M | 1.17% | 22 |
|
2018
Q4 | – | Sell |
-25,630
| Closed | -$4.94M | – | 232 |
|
2018
Q3 | $4.94M | Buy |
25,630
+15,176
| +145% | +$2.93M | 1.04% | 15 |
|
2018
Q2 | $1.78M | Buy |
10,454
+4,201
| +67% | +$714K | 0.86% | 22 |
|
2018
Q1 | $992K | Buy |
6,253
+3,198
| +105% | +$507K | 0.52% | 48 |
|
2017
Q4 | $458K | Buy |
+3,055
| New | +$458K | 0.26% | 106 |
|